Stock listing

MIRM Stock Price, News, Filings & Events — Mirum Pharmaceuticals, Inc.

Selected listing: MIRM · BOATS · USD · US

This page tracks Mirum Pharmaceuticals, Inc.'s MIRM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MIRM:BOATS. MIRM:BOATS is the stock-level entry point for investors researching Mirum Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mirum Pharmaceuticals, Inc. is a public company traded under the ticker MIRM in the American market. The company has a market capitalization of approximately $6.89 billion. Mirum focuses on developing innovative therapies for rare diseases, aiming to address unmet medical needs.

MIRM:BOATSUSDUSUpdated August 28, 2026
Mirum Pharmaceuticals, Inc. logo
Ticker
MIRM:BOATS
Asset type
Stock
Market cap
$6.33B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Mirum Pharmaceuticals, Inc. MIRM:BOATS stock context

This page tracks Mirum Pharmaceuticals, Inc.'s MIRM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MIRM:BOATS. MIRM:BOATS is the stock-level entry point for investors researching Mirum Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mirum Pharmaceuticals, Inc. is a public company traded under the ticker MIRM in the American market. The company has a market capitalization of approximately $6.89 billion. Mirum focuses on developing innovative therapies for rare diseases, aiming to address unmet medical needs.

Latest news from Mirum Pharmaceuticals, Inc.

All Mirum Pharmaceuticals, Inc. news →

Mirum Pharmaceuticals, Inc. earnings calls

Research Mirum Pharmaceuticals, Inc.

Alternate listings